Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.
KOLKATA: The National Pharmaceutical Pricing Authority (NPPA) revised prices for 80 medicines from April 1, with major cuts ...
Kolkata: The National Pharmaceutical Pricing Authority (NPPA), in an order dated March 27, changed the prices of 80 medicines ...
Earlier this week, German manufacturer Boehringer Ingelheim’s patent to manufacture Empagliflozin, a medication to treat type 2 diabetes mellitus, expired in India. Empagliflozin is sold under ...
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of 80 new drugs including anti-diabetes, anti-hypertension, pain relief formulations from major pharmaceutical companies, in its ...
So, for some people, losing weight with Jardiance may help improve their type 2 diabetes. But if you’re underweight when you start Jardiance, losing weight may have a negative effect on your health.
India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...
Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...
Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney risks, holds significant promise for volume growth as it becomes more ...
Empagliflozin improved clinical outcomes in ... EMPULSE was funded by Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance. Several authors reported receiving research support ...
Currently priced at Rs 60 per tablet, Empagliflozin’s generic versions will be available for as low as Rs 9-Rs 14 per tablet, significantly reducing costs for millions of patients, states the report.
Is Victoza similar to Januvia or Jardiance? Yes, in some ways. Victoza is used in people with type 2 diabetes to help manage blood sugar levels. It’s also used to lower the risk of severe heart ...